Clinicopathological features of thymic carcinomas and the impact of histopathological agreement on prognostical studies

European Journal of Cardio-thoracic Surgery

Volumn 43, Issue 6, 2013, Pages 1131-1139

  Roden, Anja C ^a   Yi, Eunhee S ^a   Cassivi, Stephen D ^a   Jenkins, Sarah M ^a   Garces, Yolanda I ^a   Aubry, Marie Christine ^a  

^a MAYO CLINIC ROCHESTER   (United States)

Author keywords

Interobserver agreement; Prognosis; Thymic carcinoma

Indexed keywords

ADENOCARCINOMA; ADENOSQUAMOUS CARCINOMA; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; BACKACHE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CARCINOID; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DYSPHAGIA; DYSPNEA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARGE CELL NEUROENDOCRINE CARCINOMA; MALE; MEDICAL RECORD REVIEW; METASTASIS; METASTASIS FREE SURVIVAL; MULTIPLE ENDOCRINE NEOPLASIA; MYASTHENIA GRAVIS; NIGHT SWEAT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PNEUMONIA; PRIORITY JOURNAL; SARCOMATOID CARCINOMA; SMALL CELL CARCINOMA; SQUAMOUS CELL CARCINOMA; SUPERIOR CAVA VEIN SYNDROME; THORAX PAIN; THYMOMA; THYMUS CANCER; TUMOR BIOPSY; UNCONSCIOUSNESS; UNDIFFERENTIATED CARCINOMA; WEIGHT REDUCTION;

INTEROBSERVER AGREEMENT; PROGNOSIS; THYMIC CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; OBSERVER VARIATION; PROGNOSIS; RETROSPECTIVE STUDIES; THYMOMA; THYMUS NEOPLASMS;

EID: 84878168349     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1093/ejcts/ezs529     Document Type: Article

References (22)

1. Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg 2006;81:2328-34.
2. Duwe BV, Sterman DH, Musani AI. Tumors of the mediastinum. Chest 2005;128:2893-909.
3. Okereke IC, Kesler KA, Freeman RK, Rieger KM, Birdas TJ, Ascioti AJ et al. Thymic carcinoma: outcomes after surgical resection. Ann Thorac Surg 2012;93:1668-73.
4. Roden AC, Yi ES, Bryant SC, Donovan JL, Lewis JE, Marks RS et al. Prognostic significance and reproducibility of two histological classifications for thymic epithelial tumors. Mod Pathol 2009;22(Suppl 1):1634.
5. Verghese ET, den Bakker MA, Campbell A, Hussein A, Nicholson AG, Rice A et al. Interobserver variation in the classification of thymic tumours-a multicentre study using the WHO classification system. Histopathology 2008;53:218-23.
6. Mueller-Hermelink HK, Engel P, Kuo TT, Stroebe PH, Marx A, Harris NL. Tumours of the thymus. In: Travis WD, Brambilla E, Mueller-Hermelink HKHarris CC (eds). WHO Classification of Tumours. Pathology and Genetics of Tumours of the Lung, Pleura, Thymus and Heart. IARC Press, Lyon, 2004, 146-81.
7. Koga K, Matsuno Y, Noguchi M, Mukai K, Asamura H, Goya T et al. A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma. Pathol Int 1994;44:359-67.
8. Travis WD, Brambilla E, Muller-Hermelink HK, Harris CC. Chapter 3. Pathology and genetics of tumors of the lung, pleura, thymus and heart. In: Kleihues P, Sobin LH (eds). WHO Classification of Tumors, 2nd edn. Lyon: IARC Press, 2004, 145-97.
9. Liu HC, Hsu WH, Chen YJ, Chan YJ, Wu YC, Huang BS et al. Primary thymic carcinoma. Ann Thorac Surg 2002;73:1076-81.
10. Hosaka Y, Tsuchida M, Toyabe S, Umezu H, Eimoto T, Hayashi J. Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma. Ann Thorac Surg 2010;89:912-7.
11. Tomita M, Matsuzaki Y, Edagawa M, Maeda M, Shimizu T, Hara M et al. Clinical and immunohistochemical study of eight cases with thymic carcinoma. BMC Surg 2002;2:3.
12. Kondo K, Monden Y. Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 2003;76:878-84. discussion 884-5.
13. Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg 2004;77: 1860-9.
14. Takeda S, Sawabata N, Inoue M, Koma M, Maeda H, Hirano H. Thymic carcinoma. Clinical institutional experience with 15 patients. Eur J Cardiothorac Surg 2004;26:401-6.
15. Yano M, Sasaki H, Yokoyama T, Yukiue H, Kawano O, Suzuki S et al. Thymic carcinoma: 30 cases at a single institution. J Thorac Oncol 2008; 3:265-9.
16. Chung DA. Thymic carcinoma-analysis of nineteen clinicopathological studies. Thorac Cardiovasc Surg 2000;48:114-9.
17. Koppitz H, Rockstroh JK, Schuller H, Standop J, Skowasch D, Muller-Hermelink HK et al. State-of-the-art classification and multimodality treatment of malignant thymoma. Cancer Treat Rev 2012;38:540-8.
18. Rieker RJ, Hoegel J, Morresi-Hauf A, Hofmann WJ, Blaeker H, Penzel R et al. Histologic classification of thymic epithelial tumors: comparison of established classification schemes. Int J Cancer 2002;98:900-6.
19. Marchevsky AM, Gupta R, McKenna RJ, Wick M, Moran C, Zakowski MF et al. Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 2008;112: 2780-8.
20. Muller-Hermelink HK, Marx A, Geuder K, Kirchner T. The pathological basis of thymoma-associated myasthenia gravis. Ann N Y Acad Sci 1993; 681:56-65.
21. Gadalla SM, Rajan A, Pfeiffer R, Kristinsson SY, Bjorkholm M, Landgren O et al. A population-based assessment of mortality and morbidity patterns among patients with thymoma. Int J Cancer 2010;128:2688-94.
22. Inoue Y, True LD, Martins RG. Thymic carcinoma associated with paraneoplastic polymyositis. J Clin Oncol 2009;27:e33-4.